EntryPoint Capital’s RxSight RXST Stock Holding History

EntryPoint Capital’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$101K	Buy	+16,315	New	+$135K	0.03%	704
2025 Q4	–	Sell	-10,230	Closed	-$92K	–	835
2025 Q3	$92K	Buy	+10,230	New	+$89.8K	0.04%	628
2024 Q3	–	Sell	-1,675	Closed	-$101K	–	1058
2024 Q2	$101K	Buy	1,675 +1,132	+208%	+$64.7K	0.15%	317
2024 Q1	$28K	Sell	543 -294	-35%	-$14.4K	0.03%	981
2023 Q4	$33.7K	Buy	+837	New	+$24.6K	0.03%	886

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

EntryPoint Capital's RXST Position: Q1 2026 in Review

EntryPoint Capital opened a new position in RxSight (RXST) in Q1 2026: 16,315 shares worth $101K. The stake represents 0.03% of the portfolio and ranks #704 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in RXST as recently as Q3 2025.

EntryPoint Capital first reported a position in RXST in Q4 2023 and has held it in 5 quarters since. The position peaked at $101K in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

EntryPoint Capital held 16,315 shares of RxSight worth $101K as of Q1 2026.
RxSight was a new EntryPoint Capital position in Q1 2026.
RxSight made up 0.03% of EntryPoint Capital's portfolio in Q1 2026, its #704 holding.
EntryPoint Capital first reported a position in RxSight in Q4 2023 and has held it in 5 quarters since.
EntryPoint Capital's RxSight position peaked at $101K in Q2 2024.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.